Published in
Taylor and Francis Group, OncoImmunology, p. e1323618
DOI: 10.1080/2162402x.2017.1323618
Links
Tools
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients
Journal article published in 2017 by
Cristina Maccalli 
,
Diana Giannarelli ,
Carla Chiarucci,
Ornella Cutaia,
Gianluca Giacobini,
Wouter Hendrickx ,
Giovanni Amato,
Diego Annesi,
Davide Bedognetti ,
Maresa Altomonte,
Riccardo Danielli,
Luana Calabrò,
Anna Maria Di Giacomo,
Francesco M. Marincola,
Giorgio Parmiani
and other authors.
,
Diana Giannarelli ,
Carla Chiarucci,
Ornella Cutaia,
Gianluca Giacobini,
Wouter Hendrickx ,
Giovanni Amato,
Diego Annesi,
Davide Bedognetti ,
Maresa Altomonte,
Riccardo Danielli,
Luana Calabrò,
Anna Maria Di Giacomo,
Francesco M. Marincola,
Giorgio Parmiani
and other authors.
This paper is available in a repository.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 